One-carbon metabolism biomarkers and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
01 11 2019
Historique:
received: 25 05 2018
revised: 24 12 2018
accepted: 04 01 2019
pubmed: 30 1 2019
medline: 24 1 2020
entrez: 30 1 2019
Statut: ppublish

Résumé

Published associations between dietary folate and bladder cancer risk are inconsistent. Biomarkers may provide more accurate measures of nutrient status. This nested case-control analysis within the European Prospective Investigation into Cancer and Nutrition (EPIC) investigated associations between pre-diagnostic serum folate, homocysteine, vitamins B6 and B12 and the risk of urothelial cell carcinomas of the bladder (UCC). A total of 824 patients with newly diagnosed UCC were matched with 824 cohort members. Serum folate, homocysteine, and vitamins B6 and B12 were measured. Odds ratios (OR) and 95% confidence intervals (CI) for total, aggressive, and non-aggressive UCC were estimated using conditional logistic regression with adjustment for smoking status, smoking duration and intensity, and other potential confounders. Additionally, statistical interaction with smoking status was assessed. A halving in serum folate concentrations was moderately associated with risk of UCC (OR: 1.18; 95% CI: 0.98-1.43), in particular aggressive UCC (OR: 1.34; 95% CI: 1.02-1.75; p-heterogeneity = 0.19). Compared to never smokers in the highest quartile of folate concentrations, this association seemed only apparent among current smokers in the lowest quartile of folate concentrations (OR: 6.26; 95% CI: 3.62-10.81, p-interaction = 0.07). Dietary folate was not associated with aggressive UCC (OR: 1.26; 95% CI: 0.81-1.95; p-heterogeneity = 0.14). No association was observed between serum homocysteine, vitamins B6 and B12 and risk of UCC. This study suggests that lower serum folate concentrations are associated with increased UCC risk, in particular aggressive UCC. Residual confounding by smoking cannot be ruled out and these findings require confirmation in future studies with multiple measurements.

Identifiants

pubmed: 30694528
doi: 10.1002/ijc.32165
pmc: PMC6899898
doi:

Substances chimiques

Biomarkers, Tumor 0
Homocysteine 0LVT1QZ0BA
Vitamin B 6 8059-24-3
Folic Acid 935E97BOY8
Vitamin B 12 P6YC3EG204

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2349-2359

Subventions

Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.

Références

Am J Clin Nutr. 2012 Oct;96(4):902-10
pubmed: 22952186
Am J Clin Nutr. 1994 Oct;60(4):559-66
pubmed: 8092091
Am J Clin Nutr. 2006 Apr;83(4):835-41
pubmed: 16600936
Occup Environ Med. 2004 Dec;61(12):e59
pubmed: 15550597
Nutr Cancer. 2004;48(2):142-8
pubmed: 15231448
Nutr Cancer. 2005;53(2):144-51
pubmed: 16573375
Br J Cancer. 2016 Sep 6;115(6):664-73
pubmed: 27490804
Int J Food Sci Nutr. 2014 May;65(3):286-92
pubmed: 24328495
Food Chem Toxicol. 2008 Mar;46(3):929-38
pubmed: 18054417
Eur J Clin Nutr. 2007 Sep;61(9):1037-56
pubmed: 17375121
Am J Epidemiol. 2008 Nov 1;168(9):1073-81
pubmed: 18794220
Int J Cancer. 2012 Feb 15;130(4):896-901
pubmed: 21412765
Stat Med. 2016 Feb 28;35(5):782-800
pubmed: 26619806
J Hum Nutr Diet. 2011 Apr;24(2):128-34
pubmed: 21332835
Eur Urol. 2006 Feb;49(2):226-34
pubmed: 16413099
Nutr Cancer. 2013;65(1):17-24
pubmed: 23368909
Cancer Res. 2010 Oct 15;70(20):8169-78
pubmed: 20841482
J Nutr. 2002 Aug;132(8 Suppl):2367S-2372S
pubmed: 12163694
Mol Nutr Food Res. 2011 Jan;55(1):166-80
pubmed: 21207520
Urol Oncol. 2010 Jul-Aug;28(4):401-8
pubmed: 20610278
Br J Nutr. 2003 Aug;90(2):473-9
pubmed: 12908910
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Eur J Clin Nutr. 2009 Nov;63 Suppl 4:S226-38
pubmed: 19888276
Nat Genet. 2008 Nov;40(11):1307-12
pubmed: 18794855
Am J Clin Nutr. 2005 Feb;81(2):434-9
pubmed: 15699232
Int J Cancer. 2018 Jul 15;143(2):298-306
pubmed: 29446079
Int J Epidemiol. 1997;26 Suppl 1:S6-14
pubmed: 9126529
Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3290-5
pubmed: 9096386
Carcinogenesis. 2005 Jan;26(1):177-84
pubmed: 15347601
Environ Mol Mutagen. 1989;13(4):319-24
pubmed: 2737183
Int J Cancer. 2019 Apr 15;144(8):1909-1917
pubmed: 30318764
Urol Int. 2006;77(2):152-8
pubmed: 16888422
Clin Cancer Res. 2010 Mar 1;16(5):1682-9
pubmed: 20179218
J Nutr. 2000 Feb;130(2):129-32
pubmed: 10720158
Epidemiology. 1994 Mar;5(2):218-25
pubmed: 8172997
Cancer Causes Control. 1993 Mar;4(2):157-62
pubmed: 8481494
Eur J Clin Nutr. 2003 Feb;57(2):249-59
pubmed: 12571656
Br J Nutr. 2004 Sep;92(3):489-96
pubmed: 15469653
Eur J Nutr. 2018 Mar;57(2):751-760
pubmed: 28004270

Auteurs

Alina Vrieling (A)

Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.

H Bas Bueno-De-Mesquita (HB)

National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom.
Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands.
Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Martine M Ros (MM)

Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Ellen Kampman (E)

Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
Division of Human Nutrition, Wageningen University, Wageningen, The Netherlands.

Katja K Aben (KK)

Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.

Frederike L Büchner (FL)

National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Eugène H Jansen (EH)

National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Nina Roswall (N)

Danish Cancer Society Research Center, Copenhagen, Denmark.

Anne Tjønneland (A)

Danish Cancer Society Research Center, Copenhagen, Denmark.

Marie-Christine Boutron-Ruault (MC)

Inserm, Center for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health team, Villejuif, France.
Université of Paris-Sud, Villejuif, France.
IGR, Villejuf, France.

Claire Cadeau (C)

Inserm, Center for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health team, Villejuif, France.
Université of Paris-Sud, Villejuif, France.
IGR, Villejuf, France.

Jenny Chang-Claude (J)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Germany.
Cancer Epidemiology Group, University Medical Centre Hamburg-Eppendorf, University Cancer Centre Hamburg (UCCH), Hamburg, Germany.

Rudolf Kaaks (R)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Germany.

Steffen Weikert (S)

Department of Epidemiology, German Institute of Human Nutrition, Nuthetal, Germany.
Department of Urology, Vivantes Humboldt Hospital, Berlin, Germany.

Heiner Boeing (H)

Department of Epidemiology, German Institute of Human Nutrition, Nuthetal, Germany.

Antonia Trichopoulou (A)

WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics University of Athens Medical School, Athens, Greece.
Hellenic Health Foundation, Athens, Greece.

Pagona Lagiou (P)

WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics University of Athens Medical School, Athens, Greece.
Department of Epidemiology, Harvard School of Public Health, Boston, MA.
Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece.

Dimitrios Trichopoulos (D)

Hellenic Health Foundation, Athens, Greece.
Department of Epidemiology, Harvard School of Public Health, Boston, MA.
Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece.

Sabina Sieri (S)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Domenico Palli (D)

Molecular and Nutritional Epidemiology Unit, Cancer and Prevention Institute (ISPO), Florence, Italy.

Salvatore Panico (S)

Department of Clinical and Experimental Medicine, Federico II University, Medical School, Naples, Italy.

Petra H Peeters (PH)

Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.

Elisabete Weiderpass (E)

Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Artic University of Norway, Tromsø, Norway.
Department of Research, Cancer Registry of Norway - Institute of Population-based Cancer Research, Oslo, Norway.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Genetic Epidemiology Group, Folkhälsan Research Center and Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Guri Skeie (G)

Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Artic University of Norway, Tromsø, Norway.

Paula Jakszyn (P)

Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Barcelona, Spain.

María-Dolores Chirlaque (MD)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiologia y Salud Pública), Madrid, Spain.
Department of Epidemiology, Murcia Health Authority, IMIB-Arrixaca. Murcia University, Spain.

Eva Ardanaz (E)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiologia y Salud Pública), Madrid, Spain.
Instituto de Salud Pública de Navarra, IdiSNA, Pamplona, Spain.

María-José Sánchez (MJ)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiologia y Salud Pública), Madrid, Spain.
Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

Roy Ehrnström (R)

Laboratory Medicine, Department of Pathology, Skåne University Hospital Malmö, Malmö, Sweden.

Johan Malm (J)

Department of Translational Medicine, Division of Clinical Chemistry, Lund University, Malmö, Sweden.

Börje Ljungberg (B)

Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.

Kay-Tee Khaw (KT)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Nick J Wareham (NJ)

MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.

Paul Brennan (P)

Genetic Epidemiology Group, International Agency for Research on Cancer (IARC), Lyon, France.

Mattias Johansson (M)

Genetic Epidemiology Group, International Agency for Research on Cancer (IARC), Lyon, France.
Department of Biobank Research, Umeå University, Umeå, Sweden.

Elio Riboli (E)

Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom.

Lambertus A Kiemeney (LA)

Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH